Skip to Content

Proposed Rule

You may be interested in this older document that published on 08/06/2025 with action 'Proposed rule.'
View Document

Food Standards of Identity Modernization; Pasteurized Orange Juice; Proposed Rule; Correction

A Proposed Rule by the Food and Drug Administration on 08/14/2025

Published Document: 2025-15473 (90 FR 39139)

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Document Headings

Document headings vary by document type but may contain the following:

  1. the agency or agencies that issued and signed a document
  2. the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to
  3. the agency docket number / agency internal file number
  4. the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions

See the Document Drafting Handbook for more details.

Department of Health and Human Services
Food and Drug Administration
  1. 21 CFR Part 146
  2. [Docket No. FDA-2022-P-1668]
( printed page 39139)

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Proposed rule.

SUMMARY:

The Food and Drug Administration (FDA or we) is correcting the proposed rule entitled “Food Standards of Identity Modernization; Pasteurized Orange Juice; Proposed Rule” (90 FR 37817, August 6, 2025). In the proposed rule, FDA proposed to amend the standard of identity (SOI) for pasteurized orange juice (POJ) by lowering the minimum orange juice soluble solids content from 10.5° to 10° Brix. The proposed rule inadvertently included an additional summary of benefits table, an additional summary table and an extraneous paragraph and sentence. This document corrects those errors.

DATES:

August 14, 2025.

FOR FURTHER INFORMATION CONTACT:

Keronica Richardson, Office of Policy, Regulations, and Information, Human Foods Program, Food and Drug Administration, 5001 Campus Dr., College Park, MD 20740, 240-402-2378.

SUPPLEMENTARY INFORMATION:

In FR Doc. 2025-14949, appearing on pages 37822 to 37823 in the Federal Register of Wednesday, August 6, 2025, the following corrections are made:

1. In the Supplementary Information section, in subsection VII: Preliminary Economic Analysis of Impact, on page 37822, remove the extraneous paragraph starting with the sentence, “The proposed rule, if finalized, would not require firms in the POJ industry to change their manufacturing practices or behavior in any way” and ending with the sentence, “We request comment on our described benefits and costs of the proposed rule.”

2. In the Supplementary Information section, in subsection VII: Preliminary Economic Analysis of Impact, on page 37823, remove “Table 1—Summary of Benefits, Costs and Distributional Effects of the Proposed Rule”.

3. In the Supplementary Information section, in subsection VII: Preliminary Economic Analysis of Impact, on page 37823, remove the extraneous sentence “In line with Executive Order 14192, in 2 we estimate present and annualized values of cost, cost savings, and net costs over an infinite time horizon.”

4. In the Supplementary Information section, in subsection VII: Preliminary Economic Analysis of Impact, on page 37823, remove “Table 2—E.O. 14192 Summary Table”.

The full preliminary analysis of economic impacts remains available in the docket for this proposed rule (Ref. 2) and at https://www.fda.gov/​about-fda/​economics-staff/​regulatory-impact-analyses-ria.

Dated: August 11, 2025.

Grace R. Graham,

Deputy Commissioner for Policy, Legislation, and International Affairs.

[FR Doc. 2025-15473 Filed 8-13-25; 8:45 am]

BILLING CODE 4164-01-P

Published Document: 2025-15473 (90 FR 39139)